05/14/2024
8:02 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024
9:21 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024
3:01 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
04/12/2024
3:30 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/12/2024
3:30 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B5 | |
04/10/2024
8:00 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2024
7:32 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
04/08/2024
11:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
04/08/2024
11:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
04/05/2024
8:28 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024
4:10 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
04/04/2024
3:31 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/04/2024
3:37 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
02/22/2024
7:25 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/13/2024
12:20 PM | Gordon Ariel (Filed by)
NeuroSense Therapeutics (Subject)
NeuroSense Therapeutics Ltd. (Subject)
| Form SC 13G/A | |
02/13/2024
9:14 AM | Ben-Noon Alon (Filed by)
NeuroSense Therapeutics (Subject)
NeuroSense Therapeutics Ltd. (Subject)
| Form SC 13G/A | |
02/07/2024
8:38 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/09/2024
7:48 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/09/2024
7:49 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023
4:01 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023
4:03 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
12/21/2023
7:45 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2023
3:30 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
12/14/2023
8:41 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2023
2:00 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
12/05/2023
2:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
12/05/2023
7:01 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2023
11:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
12/04/2023
5:17 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
11/28/2023
8:00 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/21/2023
9:36 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
11/13/2023
8:28 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/06/2023
7:35 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/17/2023
7:45 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/04/2023
8:12 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2023
10:39 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/29/2023
4:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2023
8:16 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/19/2023
8:15 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2023
8:20 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/07/2023
3:31 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad) Nanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront! See how with its ongoing expansion and development |
09/05/2023
11:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
07/21/2023
3:27 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
07/06/2023
7:30 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/05/2023
1:09 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/23/2023
3:05 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B5 | |
06/23/2023
3:06 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/22/2023
5:12 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B5 | |
06/13/2023
7:30 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/08/2023
8:16 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023
7:50 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2023
8:09 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
